Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NIH 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 15Genitourinary 6Sarcoma 4Breast 4Tumor-Agnostic 1Other 1Classical hematology 1

Conditions

Uterine Cervical Neoplasms 1Radiation Injuries 1Drug-Related Side Effects and Adverse Reactions 1Anemia 1

Interventions

Radiotherapy 5Methotrexate 4Cytarabine 4Cyclophosphamide 4Epoetin Alfa 3Daunorubicin 3Cyclosporine 3Thioguanine 2Peripheral Blood Stem Cell Transplantation 2Granulocyte Colony-Stimulating Factor 2Filgrastim 2Etoposide 2Dexamethasone 2Cisplatin 2Busulfan 2Asparaginase 2zosuquidar trihydrochloride 1thymoglobulin 1sargramostim 1merphos 1hydrocortisone hemisuccinate 1fludarabine 1Whole-Body Irradiation 1Vincristine 1Thrombopoietin 1Stem Cell Transplantation 1Prednisone 1Photopheresis 1Pentostatin 1Mycophenolic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Brachytherapy × Classical hematology × Clear all
NCT00017004 2017-08-09

Radiation Therapy and Cisplatin With or Without Epoetin Alfa in Treating Patients With Cervical Cancer and Anemia

GOG Foundation

Phase 3 Completed
114 enrolled
Classical hematologyGynecologic

Anemia, Uterine Cervical Neoplasms, Radiation Injuries, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡